24/7 Patient Assistance: 760-405-8205

Luke Pater, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

specialties & services

  • Bio & Insurance Information

    Dr. Luke Pater is a radiation oncologist from Cincinnati,Ohio and he works at several hospitals in the area, such as Cincinnati Children's Hospital Medical Center and Cincinnati Veterans Affairs Medical Center.He did his Medical Schooling from University of Cincinnati College of Medicine ,Internship from Christ Hospital and Residency in Radiation Oncology from University Hospital - University of Cincinnati College of Medicine. The doctor is certified in Radiation Oncology from American Board of Radiology and has an experience of more than 19 years.



  • Education & Training

    dept_icon

    University of Cincinnati

    Medical School

    dept_icon

    Christ Hospital

    Internship

    dept_icon

    University Hospital - University of Cincinnati

    Residency

  • Board Certifications

    American Board of Radiology - Radiation Oncology

  • Hospital & Practice

    University of Cincinnati Medical Center

    Languages: English/Spanish

    (513) 584-1000

    234 Goodman St

    Cincinnati, Ohio 45219

    Read More
  • Publications & Memberships

    Dr. Luke Pater has contributed to 3 publications.

    Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population.

    Pater LE Hart KW Blonigen BJ Lindsell CJ Barrett WL; Am J Clin Oncol. 2012 Oct

    See more >>

    A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids

    Haghighi K Chen G Sato Y Fan GC He S Kolokathis F Pater L Paraskevaidis I Jones WK Dorn GW 2nd Kremastinos DT Kranias EG; Hum Mutat. 2008 May .

    See more >>

    A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.

    Haghighi K Kolokathis F Gramolini AO Waggoner JR Pater L Lynch RA Fan GC Tsiapras D Parekh RR Dorn GW 2nd MacLennan DH Kremastinos DT Kranias EG; Proc Natl Acad Sci U S A. 2006 Jan 31 .

    See more >>